IFN-gamma suspends the killing license of anti-tumor CTLs.
Lukacher
Aron E
AE
Department of Pathology, Emory University School of Medicine, Atlanta, Georgia 30322, USA. alukach@emory.edu
D000818:Animals; D015703:Antigens, CD / Q000378:metabolism; D006680:HLA Antigens / Q000378:metabolism; D006801:Humans; D007108:Immune Tolerance; D007371:Interferon-gamma / Q000276:immunology*; D007694:Killer Cells, Natural / Q000276:immunology; D037181:Lectins, C-Type / Q000378:metabolism; D008024:Ligands; D051379:Mice; D018448:Models, Immunological; D051920:NK Cell Lectin-Like Receptor Subfamily D; D009369:Neoplasms / Q000276:immunology*; D011971:Receptors, Immunologic / Q000378:metabolism; D055607:Receptors, Natural Killer Cell; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*
D015703:Antigens, CD; D006680:HLA Antigens; D037181:Lectins, C-Type; D008024:Ligands; D051920:NK Cell Lectin-Like Receptor Subfamily D; D011971:Receptors, Immunologic; D055607:Receptors, Natural Killer Cell; D007371:Interferon-gamma